MCA logo
MCA logo



Deucravacitinib (Sotyktu): First-In-Class, Allosteric Tyrosine Kinase 2 (Tyk2) Inhibitor For Adults With Moderate-To-Severe Plaque Psoriasis Approved


Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

walking pneumonia
DOH Reports Full Recovery from ‘Walking Pneumonia’ Cases in the Philippines

Recently, the Department of Health (DOH) in the Philippines has taken proactive steps to clarify and address concerns surrounding Mycoplasma pneumoniae, colloquially known as ‘Walking Pneumonia.’

With four reported cases successfully recovered, the DOH aims to dissipate any apprehension by sharing detailed information about the infection’s nature, symptoms, and preventive measures.

Read More »